Close Menu

Talking Cuts

Johnson and Johnson executives discussed the company's plan to cut 6 to 7 percent of its workforce and Jacob Goldstein at the Wall Street Journal's Health Blog blogged it live. The cuts, once all in place, are estimated to save the company $1.4 to $1.7 billion a year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.